|
1
|
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.
|
Eur J Cancer
|
2002
|
1.77
|
|
2
|
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.
|
J Natl Cancer Inst
|
1989
|
1.72
|
|
3
|
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
|
Exp Clin Endocrinol Diabetes
|
2006
|
1.45
|
|
4
|
Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.
|
Lancet
|
1999
|
1.26
|
|
5
|
Cancer in pregnancy: maternal-fetal conflict.
|
J Cancer Res Clin Oncol
|
2003
|
1.08
|
|
6
|
Psychological implications of infertility in women with polycystic ovary syndrome.
|
Hum Reprod
|
2008
|
1.02
|
|
7
|
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
|
Ann Oncol
|
2011
|
1.00
|
|
8
|
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.
|
Ann Oncol
|
2012
|
0.95
|
|
9
|
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
|
Clin Cancer Res
|
2001
|
0.93
|
|
10
|
[Surgical treatment of ovarian cancer].
|
MMW Fortschr Med
|
2005
|
0.92
|
|
11
|
Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome.
|
Int J Gynecol Pathol
|
2001
|
0.92
|
|
12
|
ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.
|
Breast
|
2005
|
0.91
|
|
13
|
Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
|
Exp Clin Endocrinol Diabetes
|
2007
|
0.90
|
|
14
|
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.
|
J Clin Pathol
|
2006
|
0.88
|
|
15
|
Ventricular outflow obstruction, valve aplasia, bradyarrhythmia, pulmonary hypoplasia and non-immune fetal hydrops because of a large rhabdomyoma in a case of unknown tuberous sclerosis: a prenatal diagnosed cardiac rhabdomyoma with multiple symptoms.
|
BJOG
|
2004
|
0.88
|
|
16
|
Myomectomy as a pregnancy-preserving option in the carefully selected patient.
|
Fetal Diagn Ther
|
2002
|
0.88
|
|
17
|
Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
|
Eur J Radiol
|
2007
|
0.88
|
|
18
|
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).
|
Ann Oncol
|
2005
|
0.87
|
|
19
|
MR-guided vacuum-assisted breast biopsy with a handheld biopsy system: clinical experience and results in postinterventional MR mammography after 24 h.
|
Eur Radiol
|
2007
|
0.86
|
|
20
|
Actions of glucagon on flux rates in perfused rat liver. 1. Kinetics of the inhibitory effect on glycolysis and the stimulatory effect on glycogenolysis.
|
Eur J Biochem
|
1983
|
0.85
|
|
21
|
Parametrial invasion in cervical carcinoma: evaluation of detection at MR imaging with fat suppression.
|
Radiology
|
1998
|
0.85
|
|
22
|
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR.
|
Ann Oncol
|
2006
|
0.84
|
|
23
|
Actions of glucagon on flux rates in perfused rat liver. 2. Relationship between inhibition of glycolysis and stimulation of respiration by glucagon.
|
Eur J Biochem
|
1983
|
0.83
|
|
24
|
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
|
Eur Radiol
|
2006
|
0.83
|
|
25
|
mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus.
|
Int J Cancer
|
1997
|
0.82
|
|
26
|
Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus.
|
Int J Cancer
|
1998
|
0.81
|
|
27
|
[Magnetic resonance imaging of the pelvis in patients with polycystic ovary syndrome].
|
Rofo
|
2009
|
0.81
|
|
28
|
Early detection of maternal risk for preeclampsia.
|
ISRN Obstet Gynecol
|
2012
|
0.81
|
|
29
|
Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy.
|
Acta Obstet Gynecol Scand
|
2000
|
0.81
|
|
30
|
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.
|
Ann Oncol
|
2001
|
0.81
|
|
31
|
Morbidity of inguinofemoral lymphadenectomy in vulval cancer.
|
ScientificWorldJournal
|
2012
|
0.80
|
|
32
|
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.
|
Virchows Arch
|
2005
|
0.80
|
|
33
|
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
|
Hum Reprod
|
2014
|
0.80
|
|
34
|
[LEEP versus cold knife conization for treatment of cervical intraepithelial neoplasias].
|
Zentralbl Gynakol
|
2000
|
0.80
|
|
35
|
[Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].
|
Radiologe
|
2008
|
0.80
|
|
36
|
Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid.
|
Int J Cancer
|
1999
|
0.80
|
|
37
|
Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
|
Arch Gynecol Obstet
|
2014
|
0.79
|
|
38
|
The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.
|
Exp Clin Endocrinol Diabetes
|
2006
|
0.79
|
|
39
|
Flow cytometric detection and binding studies of human endometrial stromal cell epidermal growth factor receptor in monolayer culture: influence of progesterone.
|
Mol Hum Reprod
|
1998
|
0.78
|
|
40
|
[Magnetic resonance tomography in the diagnostics of breast implants: a survey].
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.78
|
|
41
|
[Imatinib--a possible therapeutic option for cervical carcinoma: results of a preclinical phase I study].
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.78
|
|
42
|
Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer.
|
Anticancer Res
|
2009
|
0.78
|
|
43
|
[Epidemiology and diagnosis of cervical intraepithelial neoplasia--is the present concept of screening and diagnosis still current?].
|
Gynakol Geburtshilfliche Rundsch
|
1997
|
0.78
|
|
44
|
Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.
|
Gynecol Endocrinol
|
2014
|
0.78
|
|
45
|
[Aquaporin 1 expression in invasive breast carcinomas].
|
Pathologe
|
2008
|
0.77
|
|
46
|
[The female external genitalia : pathologic findings and first steps in treatment].
|
Urologe A
|
2010
|
0.77
|
|
47
|
[Hormone replacement therapy: curse or blessing?].
|
Gynakol Geburtshilfliche Rundsch
|
2006
|
0.76
|
|
48
|
Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma.
|
Mod Pathol
|
2001
|
0.76
|
|
49
|
[MR-guided vacuum assisted breast biopsy].
|
Zentralbl Gynakol
|
2005
|
0.75
|
|
50
|
Minor role of ketone bodies in energy metabolism by skeletal muscle tissue during the postoperative course.
|
Ann Surg
|
1988
|
0.75
|
|
51
|
[Hysteroscopic staging of endometrial cancer. Comment on the contribution by R. Schild, Th. Kutter].
|
Geburtshilfe Frauenheilkd
|
1993
|
0.75
|
|
52
|
[Contraception in young adolescents].
|
Gynakol Geburtshilfliche Rundsch
|
2005
|
0.75
|
|
53
|
[Hysteroscopic surgery].
|
Arch Gynecol Obstet
|
1995
|
0.75
|
|
54
|
[Magnetic resonance imaging (MRI) of the pelvis in diagnosing endometriosis].
|
Zentralbl Gynakol
|
2005
|
0.75
|
|
55
|
[Physical integrity versus oncological safety: synthesis of important aspects in the treatment of breast cancer].
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.75
|
|
56
|
[The role of radical lymphadenectomy. Experiences from the AGO Ovarian Cancer Study Group].
|
Urologe A
|
2009
|
0.75
|
|
57
|
[Intrauterine programming of specific organ systems].
|
Gynakol Geburtshilfliche Rundsch
|
2009
|
0.75
|
|
58
|
[H1N1--pregnancy as risk factor].
|
Z Geburtshilfe Neonatol
|
2010
|
0.75
|
|
59
|
[The benefits and risks of hormonal replacement therapy--an update].
|
Gynakol Geburtshilfliche Rundsch
|
2006
|
0.75
|
|
60
|
[Immunohistologic tumor cell detection in lymph nodes in node negative breast cancer: correlation with "established" and "recent" prognostic factors].
|
Gynakol Geburtshilfliche Rundsch
|
1995
|
0.75
|
|
61
|
Magnetic resonance imaging of the female pelvis. New circularly polarized body array coil versus standard body coil.
|
Invest Radiol
|
1997
|
0.75
|
|
62
|
[MR imaging of the pelvis in characterization of adnexal masses].
|
Zentralbl Gynakol
|
2005
|
0.75
|
|
63
|
[Fundamental advances in the adjuvant systemic therapy of breast cancer].
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.75
|
|
64
|
[Diagnosis of vulval and vaginal neoplasms with magnetic resonance imaging].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
65
|
[Therapy of breast cancer--change from radical to quality-controlled individualized treatment].
|
Gynakol Geburtshilfliche Rundsch
|
2005
|
0.75
|
|
66
|
[Pathophysiology of preeclampsia].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
67
|
[New developments in reproductive medicine].
|
Gynakol Geburtshilfliche Rundsch
|
2009
|
0.75
|
|
68
|
Conservative management of Sertoli-Leydig cell tumor of the ovary.
|
Acta Obstet Gynecol Scand
|
1997
|
0.75
|
|
69
|
[Parametrial infiltration of cervix carcinoma: diagnostic value of contrast-enhanced fat-suppressed T1-weighted SE sequences at 1.5 tesla].
|
Rofo
|
1997
|
0.75
|
|
70
|
[MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
|
Rofo
|
2006
|
0.75
|
|
71
|
[Detection of microcalcifications by high-resolution B-mode sonography in patients with BI-RADS 4a lesions].
|
Gynakol Geburtshilfliche Rundsch
|
2010
|
0.75
|
|
72
|
[Hypertensive diseases during pregnancy: an interdisciplinary challenge].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
73
|
[External cephalic version in cases of breech presentation: renaissance of a well-known procedure?].
|
Gynakol Geburtshilfliche Rundsch
|
2009
|
0.75
|
|
74
|
[Endometriosis--a frequently underestimated disease].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
75
|
[Multiple pregnancies].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
76
|
[Magnetic resonance imaging (MRI) of the pelvis in the diagnosis of cervical carcinoma -- review].
|
Zentralbl Gynakol
|
2006
|
0.75
|
|
77
|
[Hormone replacement therapy and cancer risk].
|
MMW Fortschr Med
|
2008
|
0.75
|
|
78
|
Group A streptococcal toxic shock syndrome with severe necrotizing fasciitis following hysterectomy--a case report.
|
Intensive Care Med
|
1998
|
0.75
|
|
79
|
[Fetal programming].
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.75
|
|
80
|
[Paravaginal abscess in pregnancy].
|
Zentralbl Gynakol
|
2001
|
0.75
|
|
81
|
[Urinary incontinence and descensus genitalis--the silent sickness].
|
Gynakol Geburtshilfliche Rundsch
|
2006
|
0.75
|
|
82
|
[13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
|
Geburtshilfe Frauenheilkd
|
1996
|
0.75
|
|
83
|
[Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study].
|
Zentralbl Gynakol
|
1994
|
0.75
|
|
84
|
[Evaluation of the results after using of the BI-RADS categories in 1,777 clinical mammograms].
|
Radiologe
|
2008
|
0.75
|
|
85
|
[Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil].
|
Rofo
|
1997
|
0.75
|
|
86
|
[Results of long-term follow-up in treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enantone-Gyn monthly depot)].
|
Zentralbl Gynakol
|
1996
|
0.75
|
|
87
|
Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
|
Clin Ther
|
1992
|
0.75
|
|
88
|
[Prognostic value of tumor cells in bone marrow in breast cancer].
|
Gynakol Geburtshilfliche Rundsch
|
1993
|
0.75
|
|
89
|
[Multiple pregnancies--Part 2].
|
Gynakol Geburtshilfliche Rundsch
|
2007
|
0.75
|
|
90
|
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
|
Zentralbl Gynakol
|
2006
|
0.75
|
|
91
|
Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion.
|
J Clin Endocrinol Metab
|
1995
|
0.75
|
|
92
|
[Value of pelvic MRI in the preoperative diagnosis of endometriosis].
|
Rofo
|
2004
|
0.75
|
|
93
|
[Organ preservation, multimodal radical tumor therapy and reduction of therapy-related morbidity--development of diagnostics and therapy of endometrial carcinoma].
|
Gynakol Geburtshilfliche Rundsch
|
2006
|
0.75
|
|
94
|
[Stage-adapted treatment of cervical carcinoma].
|
MMW Fortschr Med
|
2007
|
0.75
|
|
95
|
Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study.
|
BJU Int
|
2002
|
0.75
|